Patent details

EP1114644 Title: Composition comprising NPH insulin (neutral protamine hagedorn insulin)

Basic Information

Publication number:
EP1114644
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP011063153
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Composition comprising NPH insulin (neutral protamine hagedorn insulin)
French Title of Invention:
Composition comportant NPH insuline (insuline protamine neutre de Hagedorn)
German Title of Invention:
Zusammensetzung die NPH-Insulin (Neutral-protamin Hagedorn Insulin) enthält
SPC Number:

Dates

Filing date:
31/07/1997
Grant date:
14/08/2002
EP Publication Date:
14/08/2002
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/07/2001
EP B1 Publication Date:
14/08/2002
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
31/07/2017
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/1997
 
 

Name:
Genentech Inc.
Address:
1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Inventor

1

Name:
CLARK Ross, G.
Address:
New Zealand (NZ)

2

Name:
YEUNG Douglas, A.
Address:
United States (US)

3

Name:
OESWEIN James, Q.
Address:
United States (US)

Priority

Priority Number:
696314
Priority Date:
13/08/1996
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/28;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
12/07/2016
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages